top of page

Cancer & Obesity

Chronic weight management pharmacotherapy has been revolutionized in the last few years by gaining FDA approval for three indications that are not weight loss, including metabolic associated fatty liver disease, established cardiovascular disease, and moderate to severe obstructive sleep apnea. This has helped improve access to care as well as focus clinical attention. While reducing excess weight has been well-known to improve cardiometabolic disease and conditions related to excess mechanical forces, the relationship between overweight/obesity and cancer is perhaps less addressed. Perhaps it is time to turn our attention to cancer risk and excess weight. After all, when cardiometabolic disease, cancer, infections, and accidents are the major causes of death and disability, excluding preventable medical errors. 


Overweight/Obesity and Cancer Risk

It is estimated that having overweight/obesity is associated with a higher risk of 13 different types of cancer, which account for 40% of all cancers. The World Health Organization estimates that 30-50% of all cancers are preventable. 


Weight Loss Reduces Cancer Risk

A real-world observational study of approximately 140,000 patients followed over 10 years showed that each 1% reduction in BMI was linked to a reduced obesity-related cancer risk at as early as 3 years. Weight loss was also associated with a lower risk of any type of cancer. Weight loss was defined by either a 5% or 10% weight loss. A 10% weight loss was associated with a larger risk reduction than a 5% weight loss. 


Weight Loss & Cancer Survivorship

The National Comprehensive Cancer Network Guidelines for Patients identify three goals for cancer survivors:

  1. Achieve a healthy weight.

  2. Maintain a healthy weight.

  3. Strive for Metabolic Health

They define metabolic health as waist circumference, blood pressure, blood sugar, triglycerides, and HDL. These things may be linked to improved survivorship.



Summary

About 40% of Americans will develop cancer in their lifetime. With an estimated 30-50% of these being preventable, and 40% of all cancers being linked to obesity, it is time to raise awareness and the conversation level on weight management for cancer prevention and cancer survivorship. 


Cancer Screenings

Studies show that people with obesity are less likely to be up to date on their age appropriate cancer screenings. Stigma and bias may be related and are important to address. Be sure to be up to date on your screenings based on your individual health and family history. If you are not sure, make an appointment with your primary care provider to review. As discussed, obesity increases the risk of 13 types of cancers, and obesity bias and stigma may be a barrier to the healthcare system achieving recommended cancer screenings among individuals with obesity.


Take Back Your Cancer Risk Reduction,


Valerie Hope-Slocum Sutherland, MD

*Artificial intelligence did not write this blog; I did.


References:


Mojtahedi, Z., & Farjadian, S. (2022). Awareness of Obesity-Related Cancers: A Complex Issue. International Journal of Environmental Research and Public Health, 19(11), 6617.



K.Alkwatli, H.Xiao, A.Mariam-Smith, et al., “Real-World Weight Loss Is Associated With a Reduction in Cancer Risk,” Obesity (2026): 1–11, https://doi.org/10.1002/oby.70163.


National Comprehensive Cancer Network



 
 
 

Recent Posts

See All
Body Composition on GLPs: Pros and Cons

Wegovy was FDA approved in 2021 and Zepbound was FDA approved in 2023. As more people are on these medications for longer and the magnitude of weight loss for some is similar to that achieved with bar

 
 
 
Navigating Your Health Journey on a GLP 1

Food Noise Over Time on GLP 1s While GLP1 medications are remarkable in their weight loss results, in clinical practice, durable outcomes are hampered by high discontinuation rates. While it is easy t

 
 
 
The Wegovy Pill is Here!

Wegovy was recently approved in tablet form in December 2025. What are the important things to know about this new treatment option? There are two differences in the FDA approval between the Wegovy in

 
 
 

Comments


Post: Blog2 Post

5713 Wollochet Drive, Ste 101

Gig Harbor, WA 98335

p: (253) 319-3339

f: (706) 416-4727

Office Hours:

Monday 3:00 - 5:00

Wednesday: 3:00 - 5:00

Virtual Physician Appointments: Wednesdays 6-8 pm, Fri: 8:30-2

In Person Physician Appointments One Friday A Month

Email melanie@rainiermedical.org and Shop Online 24/7!

  • Facebook

©2020 by rainiermd.com. Proudly created with Wix.com

bottom of page